Researchers at Lund University in Sweden headed by Professor Singerup Linse and Erik Helistrand have recently identified a molecular mechanism behind the crucial step in Alzheimer’s that leads to the death of brain cells. The neurological disease is associated, as a general statement, with memory loss and changes in personality. The research at Lund […]
A recently completed study at the University of Exeter showed that people with long-lived parents had a twenty-four percent decreased chance of getting cancer. The parameters of ‘long-lived’ defined as mothers who lived past ninety-one years and fathers who lived past eighty-seven years. A side study posted from the National Institute for Health and […]
Within the journal Science, University of Pittsburgh Graduate School of Public Health scientists confirm that a study performed on mouse models of Alzheimer’s disease had significantly improved brain function and memory capabilities after being treated with an anti-cancer drug. The cancer drug, known as bexarotene, has previously been studied and used for the treatment cutaneous […]
According to Northwestern Medicine Research, new experimental molecules have great promise in targeting enzymes in the brain that prevent memory loss in Alzheimer’s disease. Developed in D. Martin Watterson’s laboratory, the molecules halted memory loss and were able to fix damaged communication between brain cells in mice. Researchers identified and targeted a key enzyme: a […]
Drs. David Holtzman and Mac Diamond of the Washington University School of Medicine recently published research in Neuron that outlined the process of studying mice for potential tau protein tangle treatment avenues. Tau is a toxic component of Alzheimer’s and other neurodegenerative diseases, due to the protein’s tendency to amass in tangles. The aggregates, called […]
Cedars-Sinai scientists published a study in Journal of Clinical Investigation that suggests ACE inhibitors, in the right context and at the right time, can be a good thing. Many people with high blood pressure take ACE inhibitors, medication meant to widen blood vessels by limiting activity of ACE (angiotensin-converting enzyme), a naturally occurring protein. […]
A study conducted recently at the Univeraity of California- San Francisco published online in JAMA Internal Medicine. The research was focused in on finding a close link between diabetes and dementia. According to the journal, diabetic patients with low blood sugar may have an increased risk of developing dementia, and patients with dementia or other […]
Researchers at Sanford-Burnham Medical Research Institute have developed the first experimental drug named NitroMemantine that boosts brain synapses lost to Alzheimer’s disease. The medication combines two FDA-approved drugs to stop destructive cascades within the brain, which destroys the connections between neurons and ultimatly leads to memory loss and a decline in cognition. Dr. Stuart A. […]
Researchers at the Michigan Alzheimer’s Disease Center discovered that flavored ECGC, or epigallocatechi-3-gallate, found in green tea could bind to the toxic protein beta-amyloid and prevent its build-up. When ECGC binds to the protein, it is able to change beta-amyloid’s properties. Dr. Mi Hee Lim, lead researcher of the study, found that ECGC bonded to […]
A recent report from researchers at the Massachusetts General Hospital which identifies a protein that aids the immune system in the removal of A-beta protein from the brain, could lead to new treatments of Alzheimer’s disease. According to cocorresponding author of the report, Dr. Joseph Eli Khoury of the Center for Immunology and Inflammatory Diseases […]
Researchers at Duke University have identified a new type of neuron within the adult brain capable of directing stem cells to make new neurons. The experiments are preliminary, but the hope is that the brain one day could be healing itself from within. Chay Kuo, M.D, Ph.D., an assistant professor of cell biology, neurobiology, and […]
A recent study from University of California, San Francisco scientists found that a chemical in anti-wrinkle cream could effectively prevent the death of nerve cells that had been damaged by mutations which cause an inherited form of Parkinson’s disease. According to the study’s senior scientist, UCSF chemist Kevan Shokat, PhD; the study targeted an enzyme […]
Mayo clinic researchers demonstrated within a mouse model that a synthetic peptide carrier works to deliver brain cancer chemotherapy drugs, as well as neurological medications. Neuroscientist Gobinda Sarkar, Ph.D, of the Mayo Clinic and corresponding author of the study discussed that they were able to transport eight different molecules, and much less disruptively through the […]
According to research by the Washington University School of Medicine, published in Science Translational Medicine, a common antidepressant can reduce the production of brain plaques. Brain plaques correlate closely with memory problems and other cognitive impairments caused by Alzheimer’s disease. Stopping plaque buildup is believed to help halt the mental decline of Alzheimer’s patients. Scientists […]
Amino Acids Improve Sleep in Mice with Traumatic Brain Injury A study by Oregon Health and Science University, published in Science Translational Medicine, discovered a way to fix sleep disturbances in mice suffering from traumatic brain injury. These results are important, because people commonly experience long-term and severe sleep and wakefulness issues after suffering concussions, […]
In a recent study, scientists at the Queensland Brain Institute (QBI) at the University of Queensland and Harvard University have found in their research that the length of the mitochondria may be related to Alzheimer’s treatment. Mitochondria are organelles that metabolize energy for the all the cells. The scientists found in cases where there were […]
A new study recently published in the journal Annals of Neurology discussed the identification of what could be the earliest-known biomarker that is associated with the risk of developing Alzheimer’s disease. Results of the study showed that the biomarker was present within Cerebral Spinal Fluid (CSF) for at least a decade before any signs of […]
Perform a web search on “brain scam” and you will find several articles questioning the veracity of claims made with respect to brain fitness or brain exercise programs. Are these programs a scam? One thing is clear, they appear to be rapidly increasing in popularity – all the way from self help books and DVDs […]
A recent study at Vanderbilt University Medical Center conducted by Dr. Paul Newhouse and colleagues suggests that Nicotine patches may be very beneficial in individuals with mild cognitive impairment (MCI). MCI is frequently regarded as a precursor to Alzheimer’s disease and is primarily of the type that demonstrates reduction in memory while most other functions […]
The Roskamp Institute researchers show that some antibodies but, not others may be helpful in removing the Alzheimer amyloid from the brain of Alzheimer’s sufferers. Drs. Corbin Bachmeier, Daniel Paris, and Michael Mullan at the Roskamp Institute have been working on ways to improve the removal of the Alzheimer amyloid peptide from the brain. Using […]
Dr. Mullan Alzheimer Research Institute helps high school student to be involved in research……… Roskamp Institute aids high school students in genetic research Roskamp aids high school students in genetic research By JENNIFER RICH – email@example.com They look like scientists in their white coats, working in the Roskamp Institute’s lab using microscopes and high-tech research […]
The Roskamp Institute has had a long-term interest in finding new treatments for Alzheimer’s disease. Central to the goal of the institute is finding new ways to lower the accumulation of Alzheimers Abeta peptide in the brain. Drs. Michael Mullan and Daniel Paris and colleague investigated the role of an extract of tobacco, known as […]
Alzheimer’s disease: Amyloid Plaque (Excerpt from “On The Forefront”) Video shows Dr. Michael Mullan (Dr. Mullan Alzheimer Researcher at the Roskamp Institute) presenting information to audience about Alzheimer’s Disease.Beta Amyloid Presentation By Dr. Michael Mullan (Mullan Alzheimer Researcher)
Dr. Fiona Crawford presentedVideo of Alzheimer Research Institute Headed By Dr. Mullan Presentation on Traumatic Brain Injury a synopsis of her recent study of traumatic brain injury (TBI). Her recently published findings show how TBI can affect the brain’s inflammatory mechanisms, changes in protein levels and cellular pathways, long after the original trauma. Dr. Crawford’s […]
Florida Trend has recently published a lengthy article on the growing technology cluster in the Tampa Bay region in its September 24th article “Tampa Bay: Research Reigns.” The Roskamp Institute adds to the area’s biotech sector as it researches cures for neuropsychiatric and neurodegenerative disorders and has a new neuroscience doctoral research program. Visit the […]
The James & Esther King Biomedical Research Program has awarded Dr. Daniel Paris of The Roskamp Institute the Small Business Technology Transfer Grant for $100,000 to conduct a research project titled: “Treatment of Lung Adenocarcinoma and Metastasis by Anti-angiogenic Fragments of Abeta.” The Institute has previously shown that the Abeta peptite can help inhibit the […]
The Sarasota Herald Tribune reported yesterday that the Roskamp Institute was nominated for an Image Manatee Beautification Award. The Manatee Chamber of Commerce recognizes local businesses and organizations each quarter that contribute to the natural beauty of the area through their building design, use of drought-resistant landscaping, and other factors. Visit the Roskamp Institute website […]
FloridaTrend.com, a site covering business issues, explained in its article “SOUTHWEST: Eye Opener” on April 1st that the Roskamp Institute’s new neuroscience doctorate program is attracting researchers to Manatee County, which is suffering from layoffs in the home construction sector. These researchers and the facility’s work help bring more money to the county’s economy. Learn […]
Roskamp Institute Director Dr. Michael Mullan was one of many who represented the biotech industry at the Biotechnology Legislative Caucus yesterday to request more state funding in helping the industry thrive in the state. This is important to Florida this would help the state diversify its economy more, and many organizations within the state have […]
As reported in today’s Bradenton Herald, the Roskamp Institute is searching for clinical trial participants for two potential Alzheimer’s disease treatments. Bapineuzumab and ELND005 are being tested; both hope to successfully remove plaque from the brain which helps cause the condition. For more information please visit the Roskamp Institute Clinical Trial Division web page.
The Sarasota Herald-Tribune reports today in an article titled “In quest to unravel Alzheimer’s, drug may soon be tested locally” that The Roskamp Institute is planning to conduct a clinical trial of a potential Alzheimer’s disease treatment this summer. It will occur in the Sarasota, Florida area, where the Institute is located.
The Roskamp Institute’s associate director Fiona Crawford will be one of three panelists during the New College Foundation’s discussion “The Power of Women in Education” that takes place Tuesday, February 12 at the Senior Pavilion. To learn more call 487-4800 or e-mail PoWfirstname.lastname@example.org.
The Roskamp Institute announced today that it will host a neuroscience doctorate research program as part of The Open University’s — of Milton Keynes, England — Affiliated Research Centre. This is the first program of this kind in Florida and will help students prepare better for researching Alzheimer’s disease and related disorders as they work […]
The Roskamp Institute announced on December 14, 2007 that an independent Tokyo Medical University study validates its ongoing research into the Alzheimer’s Disease drug Nilvadipine which is in testing. The International Journal of Geriatric Psychiatry details the results of study that suggests that Nilvadipine can prevent in people with memory problems the onset of Alzheimer’s. […]
On December 6, 2007 the Economic Development Council (EDC) of the Manatee Chamber of Commerce presented the Roskamp Institute with the 2007 Innovation and Technology Award. The EDC honored the Institute since it has made meaningful contributions to scientific research as it studies neuropsychiatric and neurodegenerative conditions, especially Alzheimer’s Disease. The Roskamp Institute and EDC […]
The Roskamp Institute is currently determining whether beta-amyloid, a protein, is useful in the screening of individuals who are at risk of developing Alzheimer’s Disease and monitoring how current sufferers are responding to treatments. Scientists at the Institute have published their scientific findings that indicate that beta-amyloid could serve as an important biomarker for the […]
The recent findings showing that certain anti-hypertensive (drugs which lower hypertension) drugs may be helpful in Alzheimer’s disease, is consistent with the work of the Roskamp Institute. The Roskamp Institute has been conducting pioneering research in this area for several years and is currently conducting a clinical trial in Europe to test whether a […]
The Bradenton Herald reports that Dr. Fiona Crawford, Roskamp Institute’s associate director, will moderate the “The Power of Women in Medicine and Science” of the Power of Women forum series at Sainer Pavilion of the Caples Fine Arts Complex on Bay Shore Road in Sarasota. The panelists include: Sarasota Memorial Hospital president and CEO Gwen […]
The Traumatic Brain Injury Program at the Roskamp Institute Among the soldiers who survive conflicts in Iraq and Afghanistan, the traumatic brain injuries account for a larger proportion of their casualties than in any other US war in recent history. According to the Joint Theater Trauma Registry, established by the U.S. Army Institute of Surgical […]
Melanie Marquez, a reporter at the Bradenton Herald, reports that Senator Bill Nelson of Florida visited Roskamp Institute yesterday. The institute was recently funded $1.5 million by the US Department of Defense to conduct research in Traumatic Brain Injury (TBI). Roskamp Institute research work may help soldiers like those in Iraq who suffer injury due […]
Jeremy Willis of the Herald Tribune reports that U.S. Senator Bill Nelson is touring Florida during his congressional August vacation, and Melanie Marquez of the Bradenton Times explains that Nelson learned during his visit to the Roskamp Institute yesterday that it is conducting federally funded research that could help soldiers with traumatic brain injuries. The […]
While the Roskamp Institute tries to cure intellectual disabilities like Down Syndrome, ThinkCollege.net encourages and helps those with such challenges to still pursue post secondary education — including college. This is a great resource for those who have family members and friends who are bright but yet impaired.
The Bradenton Herald reports that at an economic development panel discussion on Friday sponsored by the Manatee Economic Development Council that, as a panelist, Roskamp Institute director Michael Mullan revealed that his organization brings top researchers to the area. It also provides skilled, technical jobs, but unfortunately it is hard to find suitable lab technicians […]
Yesterday, the Roskamp Institute released the results of study about obesity and Type 2 Diabetes. Here’s a link to the official press release.
Today the Roskamp Institute announced that one of its studies, led by Dr. Robert Farese, identifies a mechanism behind obesity and Type 2 Diabetes. Although the research center typically focuses on cognitive conditions like Down Syndrome, it is believed that diabetics are more likely to suffer from Alzheimer’s Disease.
If you’re looking for a science research job, check out the Roskamp Institute careers page.
In an upbeat article from February about the prospects of those who suffer from Down Syndrome and Alzheimer’s Disease, Stephanie Hayes of The St. Petersburg Times explains how the Roskamp Institute‘s trial of a new treatment for Alzheimer’s could further improve the life of those who have the disease.
Last year on World Alzheimer’s Day — September 21, 2006 — the Roskamp Institute helped celebrate a day by starting a clinical trial, and for the first time the trial is on a product of Roskamp’s own work. Hopefully, this study will yield positive results for Alzheimer’s research.
The Roskamp Institute is helping with trials for the Alzheimer’s drug Nilvadipine to get it approved for use in the United States, and the Herald Tribune in Florida reports that the human trials are going well. If all goes well with Nilvadipine, we’re one step closer to making life much better for those who suffer […]
Following is a video of a local television show on the Roskamp Institute’s new alzheimer’s treatment. roskamp roskamp institute alzheimers michael mullan
Following is a breakdown of some additional media coverage about the Roskamp Institute’s recent announcement of a new Phase III MS Study to Evaluate the Efficacy and Safety of FTY720. Following is some of the pickups. The Roskamp Institute is Participating in a New Phase III MS Study to Evaluate the Efficacy and Safety of […]
The story we featured a few weeks ago has been picked up by the Orlando Sentinel. You can read the story here. roskamp roskamp institute alzheimers michael mullan